Biologics in the treatment of severe asthma in children and adults—updates 2024-2025
Journal of Allergy and Clinical Immunology · 2026
DOI: 10.1016/j.jaci.2026.01.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026. Verfasst von Courtney L Gaberino und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis. Electronic address: gaberino@wisc.edu. Hauptthemen laut MEDLINE: Asthma, Biological Products, Anti-Asthmatic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
The development of targeted mAbs has transformed the treatment of moderate-to-severe asthma. The main clinical trial outcomes have focused on exacerbation reduction and lung function improvement. In the past few years, there have been many high-quality studies examining pathophysiologic effects of the biologic therapies, giving insight into their downstream impacts. Clinical remission is a growing area of interest, and many studies highlight the utility as well as the limitations of commonly available biomarkers to predict treatment response. This review synthesizes the results of recent clinical trials and related topics focusing on relevant updates to the literature since 2024, highlighting new indications for use, predictors of response, safety data, real-world comparative effectiveness, remission, and mechanistic advances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis. Electronic address: gaberino@wisc.edu.
- Monroe Carell, Jr, Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn.
- Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
Zitieren
APA
Gaberino, C. L., Moraczewski, J., Jackson, D. J., & Bacharier, L. B. (2026). Biologics in the treatment of severe asthma in children and adults—updates 2024-2025. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.01.002
Vancouver
Gaberino CL, Moraczewski J, Jackson DJ, Bacharier LB. Biologics in the treatment of severe asthma in children and adults—updates 2024-2025. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2026.01.002
BibTeX
@article{Gaberino2026,
author = {Gaberino, Courtney L and Moraczewski, Jason and Jackson, Daniel J and Bacharier, Leonard B},
title = {Biologics in the treatment of severe asthma in children and adults—updates 2024-2025},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
doi = {10.1016/j.jaci.2026.01.002}
}
EUVIMED